Cargando…
Intravenous infusion of angiotensin II for treatment of cardiopulmonary bypass-induced vasoplegic shock after implantation of left ventricular assist device: a case report
We report on the first successful treatment of severe pharmacoresistant vasoplegic syndrome with angiotensin II acetate (ATII) in Croatia. ATII is a novel drug used to treat severe vasoplegic shock resistant to the administration of catecholamines or alternative vasopressors such as vasopressin or m...
Autores principales: | Šribar, Andrej, Mikecin, Verica, Presečki, Ivana, Barić, Davor, Marijančević, Domagoj, Peršec, Jasminka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Medical Schools
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332295/ https://www.ncbi.nlm.nih.gov/pubmed/37391918 http://dx.doi.org/10.3325/cmj.2023.64.201 |
Ejemplares similares
-
Inflammatory Biomarkers Affecting Survival Prognosis in Patients Receiving Veno-Venous ECMO for Severe COVID-19 Pneumonia
por: Drmić, Željka, et al.
Publicado: (2023) -
Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass
por: Peyko, Vincent, et al.
Publicado: (2021) -
Organizational aspects of intensive care unit resource allocation in a primary respiratory intensive care center specialized for the treatment of SARS-COV-2 patients
por: Peršec, Jasminka, et al.
Publicado: (2020) -
HIGH-FLOW NASAL CANNULA COMBINED WITH PRONE POSITIONING AS AN INTUBATION ALTERNATIVE IN COVID-19: A CASE REPORT AND REVIEW OF THE LITERATURE
por: Sojčić, Nataša, et al.
Publicado: (2022) -
Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?
por: Bendjelid, Karim
Publicado: (2020)